Yang Cui

No. 106, Zhongshaner Road
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

The m6A demethylase FTO links TLR7 to mitochondrial oxidation driving age-associated B cell formation in systemic lupus erythematosus.

The m6A demethylase FTO links TLR7 to mitochondrial oxidation driving age-associated B cell formation in systemic lupus erythematosus.

Journal: Science translational medicine

Published: November 05, 2025

Anti-CD38 monoclonal antibody CM313 for systemic lupus erythematosus: a randomized, double-blind, placebo-controlled phase Ib/IIa trial.

Anti-CD38 monoclonal antibody CM313 for systemic lupus erythematosus: a randomized, double-blind, placebo-controlled phase Ib/IIa trial.

Journal: Signal transduction and targeted therapy

Published: May 13, 2025

Predictors of post-operative cardiovascular complications for Behçet's disease with pre-operative immunosuppressive therapy.

Predictors of post-operative cardiovascular complications for Behçet's disease with pre-operative immunosuppressive therapy.

Journal: Clinical and experimental rheumatology

Published: March 28, 2025

Evaluation of the efficacy and safety of belimumab and telitacicept in patients with systemic lupus erythematosus: results from a retrospective, observational study.

Evaluation of the efficacy and safety of belimumab and telitacicept in patients with systemic lupus erythematosus: results from a retrospective, observational study.

Journal: Clinical and experimental medicine

Published: January 26, 2025

Upregulated GDF-15 in Ankylosing Spondylitis: Pathologic Ossification Promotion through Ligament Fibroblast Osteogenic Differentiation.

Upregulated GDF-15 in Ankylosing Spondylitis: Pathologic Ossification Promotion through Ligament Fibroblast Osteogenic Differentiation.

Journal: ACR open rheumatology

Published: November 27, 2024

Increased serum level of IL-6 predicts poor prognosis in anti-MDA5-positive dermatomyositis with rapidly progressive interstitial lung disease.

Increased serum level of IL-6 predicts poor prognosis in anti-MDA5-positive dermatomyositis with rapidly progressive interstitial lung disease.

Journal: Arthritis research & therapy

Published: July 16, 2024

Species pool, local assembly processes: Disentangling the mechanisms determining bacterial α- and β-diversity during forest secondary succession.

Species pool, local assembly processes: Disentangling the mechanisms determining bacterial α- and β-diversity during forest secondary succession.

Journal: Molecular ecology

Published: April 18, 2023

Single-Cell Analysis of Patients with Axial Spondyloarthritis After Anti-TNFα Treatment: Experimental Data and Review of the Literature.

Single-Cell Analysis of Patients with Axial Spondyloarthritis After Anti-TNFα Treatment: Experimental Data and Review of the Literature.

Journal: Clinical reviews in allergy & immunology

Published: February 15, 2023

Safety of secukinumab in the treatment of patients with axial spondyloarthritis and concurrent hepatitis B virus infection or latent tuberculosis infection.

Safety of secukinumab in the treatment of patients with axial spondyloarthritis and concurrent hepatitis B virus infection or latent tuberculosis infection.

Journal: Clinical rheumatology

Published: October 31, 2022

Anti-Osteogenic Effect of Danshensu in Ankylosing Spondylitis: An in Vitro Study Based on Integrated Network Pharmacology.

Anti-Osteogenic Effect of Danshensu in Ankylosing Spondylitis: An in Vitro Study Based on Integrated Network Pharmacology.

Journal: Frontiers in pharmacology

Published: September 07, 2021

The association of transforming growth factor beta 1 gene polymorphisms with arthritis: a systematic review and meta-analysis.

The association of transforming growth factor beta 1 gene polymorphisms with arthritis: a systematic review and meta-analysis.

Journal: Clinical and experimental medicine

Published: October 10, 2020

Molecular mechanisms and clinical studies of iguratimod for the treatment of ankylosing spondylitis.

Molecular mechanisms and clinical studies of iguratimod for the treatment of ankylosing spondylitis.

Journal: Clinical rheumatology

Published: April 30, 2020

Showing 1-12 of 26

Last Updated: 09/26/2026